Skip to content

The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status

The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07383974
Enrollment
120
Registered
2026-02-03
Start date
2025-11-03
Completion date
2026-02-02
Last updated
2026-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antioxidants, Dietary Supplementation, Health Status, Healthy Volunteers, Skin Health

Brief summary

This is a randomized, double-blind, placebo-controlled clinical trial exploring the effects of a 12-week dietary supplement regimen on skin condition and perceived overall health status. The study will involve 120 healthy Chinese adults aged 18 and above with low daily fruit and vegetable intake. Participants will be randomly assigned to one of two groups: one group will take a combination of Nu Skin's Vitamin C & Green Tea Capsules and Multivitamin & Mineral Capsules, while the other group will take a matching placebo. The primary goal is to assess if the supplement combination improves skin health after 12 weeks, measured through specialized facial imaging (assessing spots, redness, evenness) and probe measurements (assessing elasticity, moisture, gloss). Secondary goals include evaluating changes in participants' self-perceived health status (via quality of life, fatigue, and digestive health questionnaires), psychological resilience, memory, and exploring a new method for measuring skin carotenoid levels. This study is not intended to verify the approved health functions of the products but to explore the potential combined effects of antioxidant and nutritional supplementation on skin and general well-being.

Interventions

DIETARY_SUPPLEMENTVitamin C & Green Tea Capsules + Multivitamin & Mineral Capsules Combination

Participants take a combination of active supplements-specifically, Vitamin C \& Green Tea Capsules and Multivitamin \& Mineral Capsules-orally twice daily.

DIETARY_SUPPLEMENTPlacebo Combination (Matching)

Participants take a matching placebo combination (identical in appearance and taste to the active supplements) orally twice daily

Sponsors

ChinaNorm
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Chinese adults of Asian descent aged 18 and above; 2. Daily fruit and vegetable intake \< 240g (calculated based on the fruit and vegetable section of the food frequency questionnaire); 3. S3 measurement index \< 30000; 4. Participants must possess basic Chinese reading comprehension and expression skills, and be able to independently complete questionnaire surveys; 5. Voluntary participation in the test and signing of the informed consent form; 6. Willingness to comply with all evaluation requirements.

Exclusion criteria

1. Presence of open facial skin lesions, clearly visible scars, acne marks, etc.; 2. Skin lesions, scars, or significant pigmentation on the hand measurement area; 3. Symptoms of skin disease on the face or hand measurement areas; 4. Having undergone medical aesthetic procedures within the last 6 months; 5. Participation in other clinical trials involving product use within the last 3 months; 6. Use of health supplements or nutritional supplements (e.g., vitamins, minerals) within the last 1 month; 7. Currently planning for pregnancy, pregnant, or lactating; 8. Presence of any disease under current treatment; 9. Any other health issues or chronic diseases that affect behavioral or cognitive abilities; 10. Other iatrogenic reasons identified by experts or professionals that may affect the evaluation results. The S3 instrument refers to a Raman spectroscopy-based biophotonic scanner. The threshold for the S3 screening value is based on previously published literature, which indicated that participants with a daily fruit and vegetable intake of less than 240g had an average Raman spectroscopy biophotonic scanner score below 25,000. However, considering practical recruitment challenges, the inclusion criterion was set at \< 30,000. The S3 device measures the Skin Carotenoid Index, a non-invasive biomarker reflecting skin carotenoid levels.

Design outcomes

Primary

MeasureTime frame
Facial Image Capture VISIA-7Imaging sessions are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
Skin Elasticity Test Probe CutometerMeasurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
Skin Gloss Measurement GlossmeterMeasurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
Skin Moisture Content CorneometerMeasurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
Skin Hemoglobin Measurement Mexameter MX18 (Courage & Khazaka, Germany)Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
Skin Moisture Loss Meter Vapometer (Delfin, Finland)Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
Skin Carotenoid IndexMeasurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).

Secondary

MeasureTime frameDescription
Skin Condition SurveyThe scales and questionnaires are administered at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).This survey assesses participants' subjective perception of their skin condition over the past month. It consists of two parts: 1) The Fitzpatrick Skin Typing Questionnaire determines the participant's skin type (I-VI) based on genetic predisposition, tanning ability, and sun reaction. 2) The Skin Status Self-Assessment uses a 100mm visual analog scale for participants to rate various aspects of their skin, including photo-damage (acute and chronic), brightness, glossiness, smoothness, hydration, pore appearance, evenness, softness, elasticity, overall wrinkles, appearance, plumpness, firmness, and spots.
Physical Health and Life Status SurveyThe survey is administered at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).This comprehensive survey evaluates participants' perceived physical health and quality of life over the past month. It incorporates five validated instruments: the SF-36 Health Survey, the Frequency of Physical Discomfort Questionnaire, the Gastrointestinal Discomfort Symptoms Questionnaire , the Population-Based Visual Fatigue Scale, and the TCM Constitution Classification and Determination Self-Assessment Table .
Psychological State and Memory LevelThe assessment is conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).This component measures participants' subjective psychological state and memory function over the past month. It uses two main instruments: 1) The Brief Resilience Scale (BRS) assesses the ability to bounce back from stress and adversity (psychological resilience). 2) The Multifactorial Memory Questionnaire (MMQ) is divided into three subscales evaluating memory satisfaction/ability (Contentment), frequency of memory failures (Ability), and the use of compensatory strategies (Strategy).
Self-Evaluation QuestionnaireThis questionnaire is administered only at follow-up visits: T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).This questionnaire is specifically designed for participants to subjectively evaluate the effects of the product intervention. It assesses perceived improvements in areas such as energy levels, overall health status, immune function, recovery speed from illness, quality of life, and the product's contribution to long-term health using a Likert scale.
Height and Weight Measurement BMIMeasurements are conducted at T0 (baseline, upon enrollment) and T12w (12 weeks).Body Mass Index (BMI) is calculated from height and weight measurements to assess weight status and changes over the intervention period.

Countries

China

Contacts

CONTACTYanwen Jiang
jiangyanwen@china-norm.com13501700841

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026